argenx SE
XBRU:ARGX

Watchlist Manager
argenx SE Logo
argenx SE
XBRU:ARGX
Watchlist
Price: 569.6 EUR
Market Cap: 34.1B EUR
Have any thoughts about
argenx SE?
Write Note

Relative Value

The Relative Value of one ARGX stock under the Base Case scenario is 982.93 EUR. Compared to the current market price of 569.6 EUR, argenx SE is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARGX Relative Value
Base Case
982.93 EUR
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
38
Median 3Y
24.5
Median 5Y
31.8
Industry
8.1
Forward
17.5
vs History
vs Industry
Median 3Y
-34.9
Median 5Y
-29
Industry
23
Forward
-767.5
vs History
vs Industry
Median 3Y
-33
Median 5Y
-33.1
Industry
23.4
vs History
vs Industry
Median 3Y
-25.9
Median 5Y
-26.1
Industry
27.3
vs History
14
vs Industry
12
Median 3Y
7.2
Median 5Y
6.9
Industry
2.6
vs History
80
vs Industry
34
Median 3Y
22.8
Median 5Y
27.3
Industry
8.1
Forward
16
vs History
33
vs Industry
30
Median 3Y
19
Median 5Y
10.8
Industry
9.6
vs History
vs Industry
Median 3Y
-34.8
Median 5Y
-28.3
Industry
4.3
Forward
-192.4
vs History
vs Industry
Median 3Y
-32.1
Median 5Y
-25.7
Industry
3.8
Forward
-173
vs History
vs Industry
Median 3Y
-27.3
Median 5Y
-27.6
Industry
6
vs History
vs Industry
Median 3Y
-22.2
Median 5Y
-22.7
Industry
3.8
vs History
69
vs Industry
12
Median 3Y
28.5
Median 5Y
40.1
Industry
4.8

Multiples Across Competitors

ARGX Competitors Multiples
argenx SE Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
33.8B USD 16.1 -101.7 -244.6 -170.3
P/E Multiple
Earnings Growth
NL
argenx SE
XBRU:ARGX
Average P/E: 211.8
Negative Multiple: -129.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -101.7 N/A
EV/EBITDA Multiple
EBITDA Growth
NL
argenx SE
XBRU:ARGX
Average EV/EBITDA: 17.9
Negative Multiple: -104.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -244.6 N/A
EV/EBIT Multiple
EBIT Growth
NL
argenx SE
XBRU:ARGX
Average EV/EBIT: 23.2
Negative Multiple: -76.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -170.3 N/A

See Also

Discover More
Back to Top